[Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. 1985

M Braun, and E de Titto

A very large number of people in both Americas are infected with T. cruzi. Nevertheless, only a relatively small percentage of them present clinical and pathological symptoms ascribable to this infection. The different immune reactions in Chagas' disease (American Trypanosomiasis) are reviewed and discussed here, both in their protective capacity and in their probable role in the pathogenesis of Chagas' disease clinical manifestations. Antibody responses are always present in infected subjects, and several types of specific antibodies have been demonstrated; their titers are high, more so in the acute phase of the disease. Their protective capacity in vivo has been demonstrated by several groups. T cell mediated immune responses (CMIR) have also been demonstrated in patients and experimental animals, but their presence is inconsistent and their level is generally low. Nevertheless, thymus dependent immune reactions are important in anti-T. cruzi protection, as shown by experiments in T deficient animals and also by some observations in immunodepressed patients. Antibody-dependent cell mediated cytotoxicity (ADCC) and natural killer (NK) cell activity directed against T. cruzi have also been proven in vitro, but their role in vivo is still unknown. There is no doubt that the immune system is able to recognize T. cruzi antigens and to protect the host against massive infection, but the immune response is not able to eliminate all the parasites, so that chronic infection ensues: this failure in "curing" the infection may be due to the above mentioned low level of CMIR and/or to escape mechanisms evolved by the parasite. The presence of immune reactions directed against self antigens in Chagas' disease patients and in experimental models of chronic Chagas' disease is also reviewed. These reactions may be due either to self antigens released by injured cells (and would then only be an epiphenomenon), or to cross-reacting antigens common to T. cruzi and normal components of the host; in fact, several cross-reactions have been proven between T. cruzi and laminin, nerve tissue antigens, etc. This would point to the possibility that autoimmune reactions play an important role in the pathogenesis of Chagas' disease clinical symptoms.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens

Related Publications

M Braun, and E de Titto
February 1991, Research in immunology,
M Braun, and E de Titto
March 2014, Expert review of anti-infective therapy,
M Braun, and E de Titto
October 1997, International archives of allergy and immunology,
M Braun, and E de Titto
November 2012, Seminars in immunopathology,
M Braun, and E de Titto
May 2020, Biochimica et biophysica acta. Molecular basis of disease,
M Braun, and E de Titto
October 2021, Current opinion in microbiology,
Copied contents to your clipboard!